Holen Sie sich die Stockscreener-App
0.1876
21.52%
-0.0225
Bio Path Holdings Inc Aktie (BPTH) Neueste Nachrichten
Life Sciences Investor Forum: Now Available for Online Viewing - The Manila Times
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Short Interest Up 870.6% in May - Defense World
Life Sciences Investor Forum Agenda Announced for June 11th-12th - GlobeNewswire
Bio-Path Holdings to Present at Life Sciences Virtual Investor F - GuruFocus
Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum | BPTH Stock News - GuruFocus
Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum - The Manila Times
Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i - The Manila Times
Roth Capital Issues Negative Estimate for Bio-Path Earnings - Defense World
Roth Capital Forecasts Bio-Path FY2029 Earnings - Defense World
“Intel Foundry Will Need to Earn (Intel’s) Business”: Intel Stock (NASDAQ:INTC) Slips as Intel Looks for Better Deal Than Intel - The Globe and Mail
When is Comtech's Q3 Earnings? Key Date and Conference Call Details Revealed - Stock Titan
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 25 | BPTH Stock News - GuruFocus
Oil-Dri Delivers Massive 16% Dividend Hike After 22 Years of Unbroken Growth - Stock Titan
Bio-Path's Breakthrough: Phase 2 Leukemia Drug Advances While New Cancer Treatments Show Promise - Stock Titan
Royalty Pharma to Share Strategic Updates at Goldman Sachs Healthcare Conference 2025 - Stock Titan
ChargePoint Q1 Earnings Show 31% Margins, Eaton Partnership Powers New Growth Strategy - Stock Titan
Roth Capital Lowers Bio-Path (BPTH) PT to $2 Amidst Pipeline Updates, Liquidity Concerns - Insider Monkey
Q.ANT Debuts First Interactive Live Demonstration and New Benchmarks for Analog Photonic Computing at ISC 2025 - Newsfile
Bio-Path's (BPTH) Price Target Reduced by Roth Capital Amid Pipe - GuruFocus
Bio-Path's (BPTH) Price Target Reduced by Roth Capital Amid Pipeline Updates | BPTH Stock News - GuruFocus
BPTH: Bio-Path's Latest Clinical Developments and Milestones | B - GuruFocus
Bio-Path Holdings Provides Clinical and Operational Update | BPT - GuruFocus
BPTH: Bio-Path's Latest Clinical Developments and Milestones | BPTH Stock News - GuruFocus
Bio-Path Holdings Provides Clinical and Operational Update - The Manila Times
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib - The Manila Times
Bio-Path Holdings Provides Clinical and Operational Update | BPTH Stock News - GuruFocus
Bio-Path Holdings, Inc. Provides Update on Clinical Development Progress and Pipeline Advances - Nasdaq
Bio-Path Clinical Trial Breakthrough: Cancer Patients Achieve Complete Remission After 15+ Treatment Cycles - Stock Titan
Auric Minerals Corp. Announces Closing of Property Transaction - The Globe and Mail
Blokees made its debut at CCXP México 2025, Officially Enters México Market - The Globe and Mail
Colgate-Palmolive Reshapes Executive Team: Danone Deputy CEO Joins as Americas COO in Strategic Growth Push - Stock Titan
Cytokinetics Management Reveals Latest Updates at Jefferies Healthcare ConferenceLive Webcast Available - Stock Titan
Transcript : Bio-Path Holdings, Inc.Special Call - marketscreener.com
Toyota Signs Rising Latin Star Ela Taubert as Tour Sponsor: Major US Concert Series Coming - Stock Titan
Revolutionary AI Nose Technology Hits 85% Accuracy, Targets $76.5B SmellTech Market for Eldercare Crisis - Stock Titan
Biotech to AI: Bionoid Pharma Makes Bold Pivot with New Identity as AI Maverick Intel - Stock Titan
Lantronix Launches Revolutionary AI Network Manager for $400M Console Server Market at Cisco Live - Stock Titan
Gentherm Leadership Team Announces Packed Schedule: 3 Key Investor Conferences Coming in June 2025 - Stock Titan
TITAN INTERNATIONAL, INC. TO PARTICIPATE IN JUNE CONFERENCES - Stock Titan
GunBroker.com Founder Takes $1 Salary as New CEO: Inside the Major Leadership Shakeup at Outdoor Holding - Stock Titan
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress - Stock Titan
Chevron Stockholders Show Overwhelming Support: Key Takeaways from 2025 Annual Meeting Results - Stock Titan
Air Products CEO Set to Share Industry Outlook at Major Deutsche Bank Industrial Conference - Stock Titan
Rigel to Present at the Jefferies Global Healthcare Conference - Stock Titan
Solid Biosciences Leadership Team to Reveal Latest Genetic Medicine Strategy at Major Healthcare Conference - Stock Titan
BlackBerry QNX Launches Game-Changing Software Platform as 90% of Future Vehicles Need Advanced Computing - Stock Titan
REX American Resources Launches Massive $32.7M Share Buyback Program Amid Strong Q1 Earnings - Stock Titan
Elanco Taps Hillenbrand CFO to Drive Next Growth Phase After 7 Straight Growth Quarters - Stock Titan
Insmed CEO Takes Stage at Goldman Sachs Healthcare Conference: Key Updates Expected - Stock Titan
Huntsman Shutters German Factory, Takes $75M Hit: European Operations Shift to US Plants - Stock Titan
Why Kingsoft Cloud Holdings Stock Plummeted by Nearly 8% Today - The Globe and Mail
3 Crypto-Centric Stocks in Focus as Bitcoin Resumes Its Rally - The Globe and Mail
Crown LNG Holdings Limited Discloses Receipt of NASDAQ Notice - The Manila Times
Bio-Path Holdings to Host Corporate Update Conference Call on Ma - GuruFocus
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025 | BPTH Stock News - GuruFocus
Bio-Path Holdings, Inc. to Host Live Conference Call on May 29, 2025, for Business Overview - Nasdaq
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025 - The Manila Times
Bio-Path Holdings to Reveal Latest Progress on Cancer Drug Pipeline and New Obesity Treatment Program - Stock Titan
Acute Myeloid Leukemia Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight - openPR.com
Marginal Zone Lymphoma Pipeline Appears Robust With 50+ Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail
Procure Space ETF (UFO) Adds Unidentified Aerial Phenomena Risk Disclosure to Prospectus - The Globe and Mail
Bio-Path (NASDAQ:BPTH) Now Covered by Analysts at StockNews.com - Defense World
QNB Corp. Declares Q2 2025 Dividend - The Globe and Mail
Bio-Path: Q1 Earnings Snapshot - CT Insider
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid - The Globe and Mail
1.91%
1.17%
Kapitalisierung:
|
Volumen (24h):